Does high hepcidin slow ferritin repletion by blocking iron absorption and trapping iron?

Hepcidin acts as the body's primary gatekeeper for iron homeostasis. Elevated levels of this hormone create a physiological "lockdown" that significantly impairs the body's ability to utilize dietary iron and replenish iron stores.

Clinical effectiveness and absorption

High hepcidin levels are a potent inhibitor of iron uptake. Research indicates a strong negative correlation (e.g., β = -0.64) between serum hepcidin and the fractional absorption of iron.

• Mechanism of action: Hepcidin binds to ferroportin—the only known mammalian cellular iron exporter—on the surface of duodenal enterocytes (intestinal cells).
• Molecular degradation: This binding triggers ubiquitination and internalization of ferroportin, leading to its degradation in lysosomes. Without ferroportin, iron taken up from the diet remains trapped inside the intestinal cells and is eventually lost when those cells are shed into the gut.
• Clinical markers: In conditions characterized by high hepcidin, such as chronic inflammation or infection, hepcidin serves as a highly specific predictor (>95%) of iron malabsorption.

Sequestration in storage cells

Hepcidin does not only block iron entry from the gut; it also prevents the movement of iron already present in the body.

• Macrophage trapping: In macrophages, which are responsible for recycling iron from old red blood cells, high hepcidin levels lead to the degradation of ferroportin, sequestering iron within these cells.
• Hepatocyte storage: Similarly, in hepatocytes (liver cells), the primary systemic iron storage site, high hepcidin prevents the release of stored iron into the plasma. This results in "functional iron deficiency," where total body iron may be adequate, but it is unavailable for red blood cell production.

Impact on ferritin repletion

The rate at which ferritin (the storage form of iron) recovers during supplementation is heavily dependent on hepcidin levels.

• Repletion trajectory: Clinical data show that baseline hepcidin levels inversely correlate with the speed of ferritin and hemoglobin recovery. High hepcidin essentially "caps" the efficiency of oral iron, regardless of the dose.
• The "hepcidin surge": High-dose oral iron supplementation can paradoxically trigger an acute spike in hepcidin. This surge reduces the absorption of subsequent doses for up to 48 hours, explaining why alternate-day dosing is often more effective for repletion than daily high doses.

Bottom line

Higher hepcidin levels significantly slow ferritin repletion by simultaneously blocking intestinal iron absorption and trapping existing iron in storage cells. This mechanism explains why iron supplementation may fail to raise ferritin levels effectively in states of inflammation or when high-dose daily protocols trigger hepcidin spikes.